PT Phapros Tbk, together with its subsidiaries, operates in the pharmaceutical industry in Indonesia. The company operates through Ethical; Over the Counter (OTC) Drugs; Generic Drugs Bearing (OCB); and Toll-in segments. It offers OTC drugs, including Antimo Anak, Antimo tablet, Livron B Plex, Becefort Sirop and tablet, Noza, Febrinex, Betafort suspensi, and Hemorogard. The company also provides ethical generic and branded products; and medical devices, as well as toll manufacturing. It also exports its products. The company was founded in 1954 and is headquartered in Jakarta Selatan, Indonesia. PT Phapros Tbk is a subsidiary of PT Kimia Farma Tbk.
Frequently asked questions
What sector does Phapros Tbk PT (PEHA) operate in?
Phapros Tbk PT belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Phapros Tbk PT (PEHA) current stock price?
As of the latest data, Phapros Tbk PT stock price is IDR 276, with a previous close of IDR 276.
What is Phapros Tbk PT (PEHA) current market capitalization?
Phapros Tbk PT market cap is approximately 231.84 billion.
What is Phapros Tbk PT (PEHA) Earnings Per Share (EPS)?
The trailing EPS is IDR 48.
What is Phapros Tbk PT (PEHA) Price-to-Earnings (P/E) ratio?
Phapros Tbk PT current P/E ratio is 5.75.
What is Phapros Tbk PT (PEHA) EBITDA?
Phapros Tbk PT EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 42.87 billion.
Does Phapros Tbk PT (PEHA) pay dividends?
Yes. Phapros Tbk PT pays annual dividends with an annualized yield of 1.82% and an estimated annual payout of IDR 5 per share.
When is the next ex-dividend date for Phapros Tbk PT (PEHA)?
The next ex-dividend date is scheduled for June 23, 2027.
What is Phapros Tbk PT (PEHA) beta (volatility) score?
Phapros Tbk PT has a beta of 0.398, indicating lower volatility than the overall market.
